Cardinal Health, the leading contract manufacturer for the
pharmaceutical industry, has announced its plans to sell its drug
manufacturing and packaging unit in order to focus on its
Bentley Pharmaceuticals has announced it will use the North
Carolina facilities of US-based services provider Cardinal Health
for the scale-up and manufacture of the clinical supplies of its
new intranasal insulin product.
Cardinal Health reported a mixed bag of results in its fourth
quarter, with revenues rising well on the back of rising demand for
its pharmaceutical distribution services, although operating profit
fell 9 per cent, in line with forecasts,...
Pharmaceutical distribution and technology company Cardinal Health
reported a slide in profits in the second quarter of the year, as
an internal investigation into the company's accounting practices
claimed additional executive...
Drug distribution and pharmaceutical technology firm Cardinal
Health has added detail to its previously announced restructuring
initiative with the news that it plans to cut 4,200 jobs and close
25 facilities around the world.
Cardinal Health reported its long-delayed fourth-quarter financial
results yesterday, revealing a hike in profit and revenues for the
three months to end June, but lowered guidance for the first half
of this fiscal year.
Healthcare giant Cardinal Health reported revenues up 11 per cent
to $14.1 billion (€11.2bn) in the fourth-quarter of 2003, as a
strong performance in its pharmaceutical manufacturing services,
pharmacy automation and medical product...